跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
monoclonal antibodies (cancer)
首页
药物
monoclonal antibodies (cancer)
monoclonal antibodies (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
EP 2439273 B1
申请人: ONO PHARMACEUTICAL CO
优先权: 2005
CN
EP
US
WO
30 件公开
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER
EP 3273993 B1
申请人: IMMUNITYBIO INC
优先权: 2015
CN
EP
US
WO
13 件公开
DETECTION OF LATE STAGES HPV INFECTION
EP 2998409 A1
申请人: ONCOHEALTH CORP
优先权: 2008
CN
EP
US
13 件公开
Monoclonal antibodies against claudin-18 for treatment of cancer
EP 1790664 A1
申请人: GANYMED PHARMACEUTICALS AG
优先权: 2005
EP
US
12 件公开
EP 1997832 A1
申请人: GANYMED PHARMACEUTICALS AG
优先权: 2007
CN
EP
US
WO
9 件公开
HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF COLON AND PANCREAS CANCER
EP 2938633 B1
申请人: PREC BIOLOGICS INC
优先权: 2012
EP
US
WO
11 件公开
Anti-mesothelin antibodies
US 2006204506 A1
申请人: EBEL WOLFGANG
优先权: 2006
US
11 件公开
MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15)
EP 3590537 A1
申请人: UNIV WUERZBURG J MAXIMILIANS
优先权: 2012
CN
EP
US
WO
10 件公开
Monoclonal antibodies for treatment of cancer
EP 1970384 A1
申请人: GANYMED PHARMACEUTICALS AG
优先权: 2007
CN
EP
US
9 件公开
EP 2166021 A1
申请人: GANYMED PHARMACEUTICALS AG
优先权: 2008
CN
EP
US
5 件公开
EP 2371864 A1
申请人: GANYMED PHARMACEUTICALS AG
优先权: 2010
EP
US
5 件公开
Methods of treating cancer using IL-21 and monoclonal antibody therapy
US 2005265966 A1
申请人: KINDSVOGEL WAYNE R
优先权: 2004
CN
US
9 件公开
Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
US 7183389 B2
申请人: MOLECULAR DISCOVERIES LLC
优先权: 2001
US
9 件公开
第 1 / 10 页
上一页
下一页
药物
反馈